Case Study: Accelerated Out-Licensing Strategy and Commercial Validation for a Phase 2 Biotech

The Challenge A Phase 2 biotechnology company needed to rapidly evaluate its competitive landscape to identify viable out-licensing partners for its lead asset. Relying on fragmented business intelligence subscriptions and siloed internal data left critical blind spots in their competitive intelligence, delaying the creation of a data-backed commercial partnering package. The Omnitheia Solution The client…